Piramal to expand in API manufacturing capabilities with $55m

Piramal Pharma Solutions (PPS) is set to invest $55m across its production sites in North America and Asia in order to expand its active pharmaceutical ingredients (API) manufacturing capabilities and capacities.

Source: Pharmaceutical Technology - October 9, 2017 Category: Pharmaceuticals Source Type: news